Cardinal Health lifted its full‑year outlook following a fiscal third‑quarter beat, now targeting adjusted earnings of $10.70 to $10.80 per share. The Ohio‑based distributor had previously guided $10.15 to $10.35, a gap that analysts at FactSet had pegged at $10.32. The upward revision reflects a surprise revenue surge that outpaced internal expectations.

Chief Executive Jason Hollar credited “momentum across multiple end markets” for the upgrade, noting that the company’s diversified health‑services platform continues to generate resilient cash flow. The latest results mark the second outlook raise this year, the first coming after the fiscal second‑quarter report in February. Investors responded positively, with the stock rallying on news of the higher earnings range.

The revised guidance narrows the spread between market forecasts and management’s target, reducing upside risk for shareholders. By confirming stronger demand for its pharmaceutical and medical‑supply distribution network, Cardinal Health positions itself to capture additional market share amid lingering supply‑chain constraints.

Overall, the earnings lift underscores the firm’s ability to translate operational gains into shareholder value, delivering a clear signal that its growth strategy remains on track.